Sabby Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Sabby Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,770	Closed	-$478K	–	364
2016 Q3	$478K	Buy	1,770 +144	+9%	+$366	0.02%	227
2016 Q2	$384K	Buy	1,626 +714	+78%	+$1.97K	0.02%	222
2016 Q1	$295K	Sell	912 -888	-49%	-$3.28K	0.01%	241
2015 Q4	$862K	Buy	1,800 +1,342	+293%	+$7.61K	0.05%	201
2015 Q3	$255K	Hold	458	–	–	0.01%	336
2015 Q2	$365K	Sell	458 -2,694	-85%	-$23.1K	0.01%	270
2015 Q1	$3.31M	Buy	+3,152	New	+$43.1K	0.14%	108

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sabby Management's BDSI Position: Q2 2017 in Review

Sabby Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2017, closing a stake of 673,342 shares — an estimated $1.28M sold.

Sabby Management first reported a position in BDSI in Q1 2015 and held it in 9 quarters. The position peaked at $2.96M in Q4 2015. 67 funds tracked by Wall St. Rank hold BDSI as of Q2 2017.

Sabby Management reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2017 after selling out during the quarter.
Sabby Management sold 673,342 BioDelivery Sciences International, Inc. shares in Q2 2017, an estimated $1.28M.
Sabby Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 9 quarters.
Sabby Management's BioDelivery Sciences International, Inc. position peaked at $2.96M in Q4 2015.
67 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2017.

Based on Sabby Management's 13F filing for Q2 2017, filed 14 Aug 2017.